FMTFMT Methodology and Patient Registry for Long-Term Safety and Effectiveness
This study aims to observe the long-term safety and effectiveness of Fecal Microbiota Transplantation (FMT) by monitoring disease re-occurrence after treatment and any related adverse events, such as surgeries, infections, hospitalizations, life-threatening events, deaths, and newly diagnosed diseases.
Data Collection
Collected from today forward - ProspectiveBacterial Infections and Mycoses+2
+ Bacterial Infections
+ Clostridium Infections
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: September 20, 2017
Actual date on which the first participant was enrolled.This study is about the Fecal Microbiota Transplant (FMT), a procedure that involves transplanting healthy bacteria from a donor into a patient's gut. The study aims to enroll 4,000 patients across 75 sites in North America who are undergoing FMT. The importance of this study lies in understanding the effectiveness and safety of FMT, as it could potentially offer a new treatment approach for various gut-related conditions. The study will collect information on the FMT methodology used, the reasons for FMT, and the patients' health status before the procedure. After the FMT, patients will be regularly monitored for up to 10 years. This includes follow-ups with the healthcare provider at 1 month, 6 months, 1 year, and 2 years post-FMT, and direct communication with patients annually until the 10th year. The study will assess the short-term and long-term safety and effectiveness of FMT. The effectiveness will be measured by monitoring disease re-occurrence after treatment. Safety will be evaluated by tracking any treatment-related adverse events, such as surgeries, infections, hospitalizations, life-threatening events, death, and newly diagnosed diseases.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.4000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 53 locations
University of Kansas Medical Center Research Institute
Kansas City, United StatesOchsner
New Orleans, United StatesBoston Children's Hospital
Boston, United States